Skin Microbiome: Cosmeceutical Development, Sample Collection & Storage and Patient Stratification
Posted 2nd January 2019 by Jane Williams
Whilst microbiome as a whole is gaining traction, developments in wound healing, skin ageing and inflammation have garnered a wider understanding of the skin microbiome in health and disease. If you were unable to attend the dedicated Skin Microbiome track at the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Madhuri Jasti, Mark Wilson and Kausar Malik available here.
Re-balancing the Skin Microbiome and Innate Immune System to Improve Skin Health
 |
Mark Wilson is the co-founder, President, and CEO of MatriSys Bioscience, a clinical stage skin microbiome company. In this presentation, he provides an update on MatriSys Bioscience’s new developments, notably their Phase 2 atopic dermatitis program.
 |
Temporal Changes in the Facial Skin Microbiome
 |
Kausar Malik discusses results from a one-year longitudinal study of the skin microbiome. Swab samples were collected from the cheek and forehead of 150 normal healthy men and women (ages 26-62) during the Cinco de Mayo holidays of May 2017 and May 2018.
 |
The complete microbiome workflow: Towards future diagnostic and clinical solutions
 |
Mahuri Jasti describes the latest tools and workflows developed for human microbiome research at Thermo Fisher Scientific, covering techniques such as sample collection & storage, next gen rapid isolation of microbial Total Nucleic Acid, initial TNA analysis and downstream analysis.
 |
Don’t miss the upcoming 7th Microbiome R&D and Business Collaboration Forum: USA. Take a look at the agenda now.
Leave a Reply